Pharmacological characterization of different fractions of Calotropis procera (Asclepiadaceae) in streptozotocin induced experimental model of diabetic neuropathy
- PMID: 24486599
- DOI: 10.1016/j.jep.2014.01.020
Pharmacological characterization of different fractions of Calotropis procera (Asclepiadaceae) in streptozotocin induced experimental model of diabetic neuropathy
Abstract
Ethnopharmacological relevance: Calotropis procera (Ait.) R.Br. is one of an ancient traditional shrub, which has been used for the treatment of diabetes, pain and inflammation for thousands of years in India. The root extract of Calotropis procera has been widely used by the tribal׳s of district Udaipur, Rajasthan (India) for treatment of diabetes mellitus and its associated complications like diabetic neuropathy. The present study was performed to explore the protective effect of root, stem and leaf extracts of Calotropis procera in diabetes and diabetic neuropathy against tactile allodynia, mechanical hyperalgesia and thermal hyperalgesia in streptozotocin induced diabetic rats.
Materials and methods: Diabetes and peripheral neuropathy were induced in Wistar rats by injection of streptozotocin (45 mg/kg/intraperitoneally). The roots, stem and leaves of Calotropis procera were sequentially extracted with petroleum ether, chloroform, ethyl acetate and methanol. All the extracts were assessed by oral administration at 100 and 250 mg/kg in streptozotocin diabetic rats. The following compounds were used as positive controls: insulin NPH (1 IU/kg/day), metformin (500 mg/kg/day), glibenclamide (2.5 mg/kg/day) and a combination of acarbose (20 mg/kg/day) with methylcobalamine (500 µg/kg/day). In contrast, the streptozotocin induced untreated diabetic rats termed as negative control. Thermal hyperalgesia, mechanical hyperalgesia and tactile allodynia were evaluated in all groups of streptozotocin diabetic rats to assess the extent of neuropathy by Eddy׳s hot plate, tail immersion, Randall-Selitto and Von Frey hair tests. The basal nociceptive thresholds were assessed in week 4 of post streptozotocin injection. All groups received their treatment on a regular basis from 28 to 42 days following a confirmation of diabetic neuropathy. The nociceptive thresholds were assessed in all groups in week 5 and 6. The histopathology of pancreas and biochemical estimations of plasma insulin and glycosylated haemoglobin (HbA1C%) levels were also performed in week 6 of post streptozotocin injection.
Results: The negative control rats developed diabetes and diabetic neuropathy after 6 week of streptozotocin administration distinguished by significant (p<0.01) hyperalgesia and tactile allodynia with enhanced HbA1C% level compared to normoglycemic rats. Chronic administration of root methanol, stem methanol and leaf ethyl-acetate extracts of Calotropis procera for 2 weeks at 100 and 250 mg/kg doses significantly (p<0.01) attenuated the diabetes induced mechanical hyperalgesia, thermal hyperalgesia, tactile allodynia and HbA1C% level in streptozotocin diabetic rats as compared to negative control rats. Further, the root methanol extract of Calotropis procera in 100mg/kg dose showed the regeneration capability of β cells in the histology of pancreas with significant (p<0.01) improvement in plasma insulin level in streptozotocin diabetic rats compared to negative control rats.
Conclusion: Root methanol extract of Calotropis procera (100mg/kg) has shown ameliorative effect in diabetic neuropathy which may be attributed by its multiple actions including potent hypoglycemic and antioxidant.
Keywords: Asclepiadaceae; Calotropis procera; Diabetes mellitus; Diabetic neuropathy; Streptozotocin.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Lycopene ameliorates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rat.Indian J Exp Biol. 2008 Feb;46(2):108-11. Indian J Exp Biol. 2008. PMID: 18335808
-
Emblica officinalis corrects functional, biochemical and molecular deficits in experimental diabetic neuropathy by targeting the oxido-nitrosative stress mediated inflammatory cascade.Phytother Res. 2011 Oct;25(10):1527-36. doi: 10.1002/ptr.3440. Epub 2011 Mar 11. Phytother Res. 2011. PMID: 21394805
-
Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy.Fitoterapia. 2012 Jun;83(4):650-9. doi: 10.1016/j.fitote.2012.01.010. Epub 2012 Feb 9. Fitoterapia. 2012. PMID: 22343014
-
Streptozotocin-Induced Diabetes Mellitus in Neonatal Rats: An Insight into its Applications to Induce Diabetic Complications.Curr Diabetes Rev. 2019;16(1):26-39. doi: 10.2174/1573399815666190411115829. Curr Diabetes Rev. 2019. PMID: 30973111 Review.
-
Diabetic painful and insensate neuropathy: pathogenesis and potential treatments.Neurotherapeutics. 2009 Oct;6(4):638-47. doi: 10.1016/j.nurt.2009.07.004. Neurotherapeutics. 2009. PMID: 19789069 Free PMC article. Review.
Cited by
-
Metformin: A Prospective Alternative for the Treatment of Chronic Pain.Front Pharmacol. 2020 Sep 23;11:558474. doi: 10.3389/fphar.2020.558474. eCollection 2020. Front Pharmacol. 2020. PMID: 33178015 Free PMC article. Review.
-
Antidiabetic activities of aqueous ethanol and n-butanol fraction of Moringa stenopetala leaves in streptozotocin-induced diabetic rats.BMC Complement Altern Med. 2015 Jul 18;15:242. doi: 10.1186/s12906-015-0779-0. BMC Complement Altern Med. 2015. PMID: 26187590 Free PMC article.
-
Investigation of Natural Compounds for Therapeutic Potential in Streptozotocin-induced Diabetic Neuroinflammation and Neuropathic Pain.Front Pharmacol. 2022 Oct 5;13:1019033. doi: 10.3389/fphar.2022.1019033. eCollection 2022. Front Pharmacol. 2022. PMID: 36278164 Free PMC article.
-
Siddha Medicine in Eastern Sri Lanka Today-Continuity and Change in the Treatment of Diabetes.Front Pharmacol. 2018 Oct 10;9:1022. doi: 10.3389/fphar.2018.01022. eCollection 2018. Front Pharmacol. 2018. PMID: 30364250 Free PMC article.
-
New Advances on Pathophysiology of Diabetes Neuropathy and Pain Management: Potential Role of Melatonin and DPP-4 Inhibitors.Front Pharmacol. 2022 Apr 12;13:864088. doi: 10.3389/fphar.2022.864088. eCollection 2022. Front Pharmacol. 2022. PMID: 35496279 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical